Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Formative perceptions of a digital pill system to measure adherence to heart failure pharmacotherapy: Qualitative Research
ABSTRACT
Background:
Heart failure affects 6.2 million Americans and is a leading cause of hospitalization. Despite effective pharmacologic options, adherence is suboptimal. Digital pill systems (DPS) which use an ingestible radiofrequency emitter to directly measure medication ingestions in real-time represent a strategy for measuring and responding to nonadherence in the context of heart failure pharmacotherapy.
Objective:
To explore responses and perceived barriers to using the DPS to monitor pharmacotherapy adherence among patients with heart failure.
Methods:
Individual, semi-structured qualitative interviews and quantitative assessments were conducted between April and August 2022. Twenty patients with heart failure who were admitted to the general medical or cardiology service at an urban quaternary care hospital participated. Participants completed a qualitative interview exploring responses to the technology and perceived barriers to DPS use, and a quantitative assessment on heart failure history, existing medication adherence strategies, and attitudes towards technology. Qualitative data were analyzed using applied thematic analysis and NVivo software.
Results:
Most participants (60%) reported a willingness to use the DPS to measure heart failure medication adherence. Overall, the DPS was viewed as useful for increasing accountability and reinforcing adherence behavior. Perceived barriers included technological issues, lack of need, additional costs, and privacy concerns. Most were open to sharing adherence data with providers to bolster clinical care and decision-making. Reminder messages following detected nonadherence were perceived as a key feature, and customization was desired. Suggested improvements primarily related to the design and usability of the Reader.
Conclusions:
Overall, individuals with heart failure perceived the DPS to be an acceptable and useful tool for measuring medication adherence. The DPS links technology to clinical medicine and can be integrated into treatment plans to optimize adherence management and inform behavioral interventions to boost adherence among heart failure patients.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.